# An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition.

> **NCT04086719** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 16 (actual)

## Conditions studied

- Healthy Male Volunteers

## Interventions

- **DRUG:** BMS-986165
- **DRUG:** Pyrimethamine

## Key facts

- **NCT ID:** NCT04086719
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-12
- **Primary completion:** 2019-10-29
- **Final completion:** 2019-10-29
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04086719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04086719, "An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04086719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*